• Contact Us
  • New Tenders
  • Register
  • Login

Civil Works of SPMC Lotus Pharma Project

SrilankaTender notice for Civil Works of SPMC Lotus Pharma Project. The reference ID of the tender is 63858060 and it is closing on 21 Mar 2022.

Tender Details

  • Country: Sri Lanka
  • Summary: Civil Works of SPMC Lotus Pharma Project
  • LKT Ref No: 63858060
  • Deadline: 21 Mar 2022
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: SPMC/ LP/003/2022
  • Purchaser's Detail:
  • Purchaser : STATE PHARMACEUTICALS MANUFACTURING CORPORATION (SPMC) OF SRI LANKA
    Chairman - Procurement Committee for Lotus Pharma Project State Pharmaceuticals Manufacturing Corporation, No: 11 Sir John Kotelawala Mavvatha, Kandawala Estate, Ratmalana. Tel 2635353 / 2637574 /2623298 Fax: 2634771 /2626621
    URL :www.spmclanka.com

  • Description:
  • Tenders are invited for Civil Works of SPMC Lotus Pharma Project Non-refundable Bid Fee: Rs. 20,000.00 Bid Bond Value and Validity: Rs. 1,500,000.00 Up to 120 days from closing date
  • Documents:

 Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
SrilankaTender Features

SrilankaTender Features

Fresh and verified Tenders from Srilanka. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM
Tender Experts

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Captcha Image
Invalid Captcha !

Get FREE SAMPLE TENDERS from Srilanka in your email inbox.

  Chat with us